Huntington National Bank’s AIM ImmunoTech AIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1
Closed -$7 4335
2025
Q1
$7 Hold
1
﹤0.01% 3835
2024
Q4
$11 Hold
1
﹤0.01% 3725
2024
Q3
$15 Hold
1
﹤0.01% 3612
2024
Q2
$21 Hold
1
﹤0.01% 3431
2024
Q1
$27 Hold
1
﹤0.01% 3150
2023
Q4
$25 Hold
1
﹤0.01% 3102
2023
Q3
$26 Hold
1
﹤0.01% 3051
2023
Q2
$38 Hold
1
﹤0.01% 2803
2023
Q1
$25 Hold
1
﹤0.01% 2897
2022
Q4
$18 Hold
1
﹤0.01% 2915
2022
Q3
$0 Hold
1
﹤0.01% 3152
2022
Q2
$0 Hold
1
﹤0.01% 3156
2022
Q1
$0 Hold
1
﹤0.01% 3078
2021
Q4
$0 Hold
1
﹤0.01% 3003
2021
Q3
$0 Hold
1
﹤0.01% 2724
2021
Q2
$0 Hold
1
﹤0.01% 2614
2021
Q1
$0 Hold
1
﹤0.01% 2505
2020
Q4
$0 Hold
1
﹤0.01% 2482
2020
Q3
$0 Hold
1
﹤0.01% 2425
2020
Q2
$0 Hold
1
﹤0.01% 2441
2020
Q1
$0 Hold
1
﹤0.01% 2534
2019
Q4
$0 Hold
1
﹤0.01% 2543
2019
Q3
$0 Hold
1
﹤0.01% 2452
2019
Q2
$0 Hold
1
﹤0.01% 2485
2019
Q1
$0 Hold
1
﹤0.01% 2482
2018
Q4
$0 Hold
1
﹤0.01% 2533
2018
Q3
$0 Hold
1
﹤0.01% 2517
2018
Q2
$0 Buy
+1
New +$1.46K ﹤0.01% 1715

Other funds holding AIM

Huntington National Bank's AIM Position: Q2 2025 in Review

Huntington National Bank sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 1 share — an estimated $7 sold.

Huntington National Bank first reported a position in AIM in Q2 2018 and held it in 28 quarters. The position peaked at $38 in Q2 2023. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.

  • Huntington National Bank reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
  • Huntington National Bank sold 1 AIM ImmunoTech share in Q2 2025, an estimated $7.
  • Huntington National Bank first reported a position in AIM ImmunoTech in Q2 2018 and held it in 28 quarters.
  • Huntington National Bank's AIM ImmunoTech position peaked at $38 in Q2 2023.
  • 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.

Based on Huntington National Bank's 13F filing for Q2 2025, filed 5 Aug 2025.